Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-001472·Atea Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Atea Pharmaceuticals Inc
Common Stock · CUSIP: 04683R106
Event date: 2025-03-31
- Filing-level shares
- 6,082,350
- Percent of class
- 7.1%
- BlackRock, Inc.
Shares: 6,082,350 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001472
- Form type
- SCHEDULE 13G/A
- Filer
- Atea Pharmaceuticals, Inc.
- CIK
- CIK 1593899
- Filed
- Apr 23, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership